Skip to content
★ Sign in to follow
JP

James P. Gilligan

Unigene Laboratories IncHerborium
Total declarations
10
Companies
2
▲ Purchases (2 ops.)
€6,868
▼ Sales (3 ops.)
€135k

Latest filing published 20 Jan 2010 for UNIGENE LABORATORIES INC.

Insider track record

Disclosed buys
2
Disclosed sells
3
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

James P. Gilligan: trading record in brief

James P. Gilligan has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Unigene Laboratories Inc and Herborium. We count 10 filings; the first trade dates from 21 December 2005 and the latest from 15 January 2010.

Both buying and selling appear: 2 purchases worth €6,868, against 3 sales worth €135k. On balance, insiders were net sellers of €128k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants and 2 option exercises.

The record was last updated on 20 January 2010 with a share grant in Unigene Laboratories Inc. The last insider purchase was made public on 8 October 2008, 6,606 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to James P. Gilligan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total

10 of 10 declarations